INFLUENCE OF THE INTERVAL OF TIME BETWEEN ANTI-TNF AND VEDOLIZUMAB OR USTEKINUMAB IN THE RESPONSE TO TREATMENT IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
Iria Bastón-Rey 1
Manuel Barreiro de Acosta 1
Marta Costa 1
Cristina Calviño Suarez 1
Maria Violeta Mauriz Barreiro 1
Daniel de la Iglesia-Garcia 1
Jaime González 1
Rocío Ferreiro-Iglesias 1
Juan Enrique Dominguez-Munoz 1
1 University Hospital of Santiago de Compostela, Santiago de Compostela, Spain
Session
IBD (Posters)
Conference
UEG Week Virtual 2020
Citation
United European Gastroenterology Journal 2020; 8 (Supplement 1)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]